RT Journal Article
SR Electronic
T1 The promise of targeted therapy: Cancer drugs become more specific
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 551
OP 560
VO 71
IS 7
A1 Segota, Ena
A1 Bukowski, Ronald M.
YR 2004
UL http://www.ccjm.org/content/71/7/551.abstract
AB Toxic chemotherapeutic agents are slowly being supplemented by a new generation of drugs that recognize specific targets in or on cancer cells. Although these molecular and genetic approaches are in their infancy, they hold the promise of more effective therapies with markedly fewer side effects. Several targeted agents are already approved by the US Food and Drug Administration (FDA) for use in malignancies, and numerous others are in clinical trials.